These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 3098259)

  • 1. Effect of paraventricular nucleus lesions on body weight, food intake and insulin levels.
    Sims JS; Lorden JF
    Behav Brain Res; 1986 Dec; 22(3):265-81. PubMed ID: 3098259
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Destruction of noradrenergic innervation to the paraventricular nucleus: deficits in food intake, macronutrient selection, and compensatory eating after food deprivation.
    Shor-Posner G; Azar AP; Jhanwar-Uniyal M; Filart R; Leibowitz SF
    Pharmacol Biochem Behav; 1986 Aug; 25(2):381-92. PubMed ID: 3094038
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clonidine hyperphagia: neuroanatomic substrates and specific function.
    Shor-Posner G; Azar AP; Volpe M; Grinker JA; Leibowitz SF
    Pharmacol Biochem Behav; 1988 Aug; 30(4):925-32. PubMed ID: 3147461
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lesions of the hypothalamic paraventricular nucleus and norepinephrine turnover in rats.
    Yoshida T; Yoshioka K; Nishioka H; Kondo M
    Endocrinol Jpn; 1989 Apr; 36(2):187-94. PubMed ID: 2776698
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of vagotomy on serum insulin in rats with paraventricular or ventromedial hypothalamic lesions.
    Tokunaga K; Fukushima M; Kemnitz JW; Bray GA
    Endocrinology; 1986 Oct; 119(4):1708-11. PubMed ID: 3530723
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ventromedial hypothalamic and paraventricular nucleus lesions damage a common system to produce hyperphagia.
    Cox JE; Sims JS
    Behav Brain Res; 1988 Jun; 28(3):297-308. PubMed ID: 3293612
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dynamic and static phases of obesity following lesions in PVN and VMH.
    Fukushima M; Tokunaga K; Lupien J; Kemnitz JW; Bray GA
    Am J Physiol; 1987 Sep; 253(3 Pt 2):R523-9. PubMed ID: 3307460
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Feeding behavior induced by central norepinephrine injection is attenuated by discrete lesions in the hypothalamic paraventricular nucleus.
    Leibowitz SF; Hammer NJ; Chang K
    Pharmacol Biochem Behav; 1983 Dec; 19(6):945-50. PubMed ID: 6657727
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronic norepinephrine injection into the hypothalamic paraventricular nucleus produces hyperphagia and increased body weight in the rat.
    Leibowitz SF; Roossin P; Rosenn M
    Pharmacol Biochem Behav; 1984 Nov; 21(5):801-8. PubMed ID: 6514770
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased feeding and neuropeptide Y (NPY) but not NPY mRNA levels in the hypothalamus of the rat following central administration of the serotonin synthesis inhibitor p-chlorophenylalanine.
    Dryden S; Frankish HM; Wang Q; Williams G
    Brain Res; 1996 Jun; 724(2):232-7. PubMed ID: 8828573
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Morphine-stimulated feeding: analysis of macronutrient selection and paraventricular nucleus lesions.
    Shor-Posner G; Azar AP; Filart R; Tempel D; Leibowitz SF
    Pharmacol Biochem Behav; 1986 Apr; 24(4):931-9. PubMed ID: 3086905
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PVN-hindbrain pathway involved in the hypothalamic hyperphagia-obesity syndrome.
    Kirchgessner AL; Sclafani A
    Physiol Behav; 1988; 42(6):517-28. PubMed ID: 3166142
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The hypothalamic paraventricular nucleus is not essential for orexigenic NPY or anorexigenic melanocortin action.
    Dube MG; Kalra SP; Kalra PS
    Peptides; 2006 Sep; 27(9):2239-48. PubMed ID: 16759748
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypophysectomy disturbs the noradrenergic feeding system of the paraventricular nucleus.
    Roland CR; Oppenheimer RL; Chang K; Leibowitz SF
    Psychoneuroendocrinology; 1985; 10(1):109-20. PubMed ID: 4001276
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuromedin U receptor 2 knockdown in the paraventricular nucleus modifies behavioral responses to obesogenic high-fat food and leads to increased body weight.
    Benzon CR; Johnson SB; McCue DL; Li D; Green TA; Hommel JD
    Neuroscience; 2014 Jan; 258():270-9. PubMed ID: 24269937
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Feeding behavior after hypothalamic 6-hydroxydopamine injections.
    Leibowitz SF
    Appetite; 1984 Sep; 5(3):268-71. PubMed ID: 6441518
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypothalamic paraventricular nucleus: interaction between alpha 2-noradrenergic system and circulating hormones and nutrients in relation to energy balance.
    Leibowitz SF
    Neurosci Biobehav Rev; 1988; 12(2):101-9. PubMed ID: 2845312
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Histochemical and pharmacological analysis of noradrenergic projections to the paraventricular hypothalamus in relation to feeding stimulation.
    Leibowitz SF; Brown LL
    Brain Res; 1980 Nov; 201(2):289-314. PubMed ID: 7417844
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Paraventricular hypothalamic obesity in rats: role of corticosterone.
    King BM; Zansler CA; Richard SM; Gutierrez C; Dallman MF
    Physiol Behav; 1992 Jun; 51(6):1207-12. PubMed ID: 1641422
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glucose-dependent changes in alpha 2-noradrenergic receptors in hypothalamic nuclei.
    Jhanwar-Uniyal M; Papamichael MJ; Leibowitz SF
    Physiol Behav; 1988; 44(4-5):611-7. PubMed ID: 2853387
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.